Please use this identifier to cite or link to this item:
Title: How healthy is community-dwelling elderly population? Results from southern Italy
Authors: Guerriero, Francesca
Orlando, Valentina
Tari, Daniele Ugo
Di Giorgio, Annalisa
Cittadini, Antonio
Trifirò, Gianluca
Menditto, Erica
Keywords: Polypharmacy
Administrative databases
Geriatric assessment
Issue Date: 2015
Citation: Guerriero F, Orlando V, Tari Daniele U, Di Giorgio A, Cittadini A, Trifirò G, Menditto E. How healthy is community-dwelling elderly population? Results from southern italy. Translational Medicine @ UniSa 2015, 13(9): 59-64
Abstract: PURPOSE To explore the frequency of polypharmacy, functional and cognitive capacity among the elderly in Southern Italy. METHODS Populationbased retrospective cross-sectional study. Information were retrieved from electronic-geriatric-forms matched by record-linkage to outpatient pharmacy-records. The following domains were collected from geriatric forms: BMI, cognitive capacity (SPMSQ), functional status Barthel-index), mobility, living condition. Polypharmacy status was categorized as non-polypharmacy (0-4), polypharmacy (5-9) and excessive-polypharmacy (>10). Prevalence of all variables were stratified by age and polypharmacy group. RESULTS 88,878 old people received a geriatric assessment in the years 2013-2014. Mean age was 74.8 (±7.3) years, 56.6% females. Proportion of elderly in excessive-polypharmacy increased with age (18.9% in 65-75 age-group; 27.9% in >85). Referring to cognitive capacity, the proportion of lucid patients decreased with age (from 94.3% to 58.1%), while confused patient increased with age (from 4.7% to 30.9%). Proportion of subjects with a decline in cognitive status, functional status and mobility increased in polypharmacy and excessive polypharmacy group. CONCLUSION Polypharmacy is common in people aged 65 years and older with difficulties in activities of daily living and impaired cognition. Furthermore, its prevalence raises with increasing age. Preventive strategies such us optimization of drug regimen should be performed routinely to reduce risk of adverse-health-events.
ISSN: 2239-9747
Appears in Collections:Translational Medicine @ UniSa. Volume 13 (sept.-dec. 2015)

Files in This Item:
File Description SizeFormat 
09.pdfTranslational Medicine @ UniSa 2015, 13(9): 59-64169,97 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.